Contains standardised dry extract from Silybum Marianum fruits (35-45:1) 200mg corresponding to 52.5% Silymarin ( silibinin, HPLC) the gold standard in phyto-pharmaceuticals liver protection preparation.

Cefasily is approved in German Commission E Monograph as a supportive treatment for inflammatory liver conditions such as cirrhosis, hepatitis and fatty liver .

Cefasily protect the liver against alcohol, toxins and promotes regeneration of liver cells. Cefasily is well tolerated and suitable for long term treatment of liver disease.